S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
OTCMKTS:LZAGY

Lonza Group Stock Forecast, Price & News

$61.34
+0.66 (+1.09 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$60.82
Now: $61.34
$61.43
50-Day Range
$60.41
MA: $63.65
$68.66
52-Week Range
$32.09
Now: $61.34
$68.99
Volume60,352 shs
Average Volume105,640 shs
Market Capitalization$45.68 billion
P/E Ratio44.77
Dividend Yield0.35%
Beta0.75
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma Biotech & Nutrition, and Specialty Ingredients. The Pharma Biotech & Nutrition segment provides technology platforms, including drug substance and drug product; and develops and manufactures customized active pharmaceutical ingredients and biopharmaceuticals, as well as formulation services and delivery systems for pharmaceutical and nutritional applications. It serves pharmaceutical companies, biotechnology firms, and medical research and testing organizations, as well as consumer health and nutrition companies. The Specialty Ingredients segment operates microbial control solutions and specialty chemical services businesses. Its Microbial control solutions business has offerings in professional hygiene, and home and personal care markets; and offerings in paints and coating, wood protection, material protection, and crop protection. This segments also offers specialty chemicals in electronics, aerospace, food and feed ingredients, agro chemicals, and diversified specialty chemicals markets. The company has collaboration with Moderna, Inc. to manufacture a potential COVID-19 vaccine, mRNA-1273. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Lonza Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars


Industry, Sector and Symbol

Industry Tobacco products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:LZAGY
CUSIPN/A
CIKN/A
Phone41-61-316-8111
Employees15,913

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$978.37 million
Cash Flow$1.35 per share
Book Value$8.87 per share

Profitability

Miscellaneous

Market Cap$45.68 billion
Next Earnings DateN/A
OptionableNot Optionable
$61.34
+0.66 (+1.09 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LZAGY News and Ratings via Email

Sign-up to receive the latest news and ratings for LZAGY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lonza Group (OTCMKTS:LZAGY) Frequently Asked Questions

How has Lonza Group's stock been impacted by Coronavirus?

Lonza Group's stock was trading at $38.43 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LZAGY stock has increased by 59.6% and is now trading at $61.34.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Lonza Group?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Lonza Group
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Lonza Group?

Wall Street analysts have given Lonza Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lonza Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Lonza Group?

Lonza Group saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 15,400 shares, an increase of 180.0% from the October 31st total of 5,500 shares. Based on an average daily volume of 114,600 shares, the short-interest ratio is presently 0.1 days.
View Lonza Group's Short Interest
.

Who are some of Lonza Group's key competitors?

Who are Lonza Group's key executives?

Lonza Group's management team includes the following people:
  • Dr. Pierre-Alain Ruffieux, Chief Exec. Officer (Age 50)
  • Mr. Rodolfo J. Savitzky, Chief Financial Officer (Age 58)
  • Mr. Dirk Oehlers, VP of Investor Relations
  • Victoria Morgan, Head of Corp. Communications
  • Mr. Joseph R. Colleluori, Sr. VP of Corp. Devel.
  • Ms. Jennifer Clancy, Sr. Director of Global Marketing
  • Ms. Caroline Barth, Chief HR Officer
  • Ms. Constance Ward, Head of External Communications
  • Mr. Stefan Stoffel, Chief Operating Officer of Lonza Pharma Biotech & Nutrition (Age 54)
  • Dr. Sanna Fowler, Head of External Communications

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $61.34.

How big of a company is Lonza Group?

Lonza Group has a market capitalization of $45.68 billion and generates $978.37 million in revenue each year. The company earns $649.19 million in net income (profit) each year or $1.37 on an earnings per share basis. Lonza Group employs 15,913 workers across the globe.

What is Lonza Group's official website?

The official website for Lonza Group is www.lonza.com.

How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The company can be reached via phone at 41-61-316-8111 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.